BROS
Dutch Bros Inc.
BROS has the edge over TSLA overall, supported by stronger valuation and stronger modeled upside.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
BROS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BROS's revenue, profitability, cash flow and balance sheet are all currently healthy.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
BROS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 31x | $33.71 | — |
| Current | 43x | $33.71 | — |
| Cheap | 88x | $68.51 | +103% |
| Fair | 162x | $126 | +275% |
| Expensive | 567x | $442 | +1213% |
Historical ranges are pointers, not guarantees.
BROS has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
BROS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BROS, with profitability holding steady. However, they disagree widely on these estimates.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
BROS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.10 | +41% |
| Q3 2026 | $0.78 | +56% |
| Q2 2026 | $0.72 | +53% |
| Q1 2026 | $0.64 | +64% |
| Q4 2025 | $0.64 | +88% |
| Q3 2025 | $0.50 | +72% |
| Q2 2025 | $0.47 | +88% |
| Q1 2025 | $0.39 | +117% |
| Q4 2024 | $0.34 | +1033% |
BROS has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
BROS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $549.8M | +30% |
| Q2 2026 | $550.9M | +32% |
| Q1 2026 | $464.4M | +31% |
| Q4 2025 | $443.6M | +29% |
| Q3 2025 | $423.6M | +25% |
| Q2 2025 | $415.8M | +28% |
| Q1 2025 | $355.2M | +29% |
| Q4 2024 | $342.8M | +35% |
BROS has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.6% | -0.2 points |
| Q2 2026 | 13% | -0.4 points |
| Q1 2026 | 7.4% | -1.4 points |
| Q4 2025 | 7.7% | +3.1 points |
| Q3 2025 | 9.8% | +0.2 points |
| Q2 2025 | 13% | +3.2 points |
| Q1 2025 | 8.8% | -0.6 points |
| Q4 2024 | 4.6% | +3.7 points |
BROS has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
BROS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.8M | -22% |
| Q2 2026 | $39.9M | +12% |
| Q1 2026 | $27.7M | +$36.4M |
| Q4 2025 | $8.5M | -56% |
| Q3 2025 | $18.9M | -28% |
| Q2 2025 | $35.7M | +$40.6M |
| Q1 2025 | -$8.7M | +$7.6M |
| Q4 2024 | $19.5M | +$35.2M |
BROS has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
BROS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +3.4M shares |
| 1 year | +8.5% | +10.8M shares |
| 3 years | +141% | +80.8M shares |
| 5 years | +195% | +91.4M shares |
| Available history | +181% | +89.1M shares |
BROS has 138M diluted shares, up 8.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over BROS on shareholder dilution, with a more favorable share count trend.
BROS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
BROS's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over BROS on leverage, with a lower net debt burden relative to earnings.
BROS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 8.2 | Oversold |
BROS's weekly RSI is 31 (neutral) and its Stochastic is 8 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
BROS PE vs Consumer Cyclical Sector
| Metric | BROS | Sector median | Relative |
|---|---|---|---|
| PE | 43x | 18x | 140% above |
| PE % | 0 | 57 | 57 pts below |
BROS has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
BROS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 12% below |
| 20 week MA | $49.0 | 31% below |
| 50 week MA | $53.8 | 37% below |
| 100 week MA | $58.1 | 42% below |
| 200 week MA | $45.3 | 26% below |
BROS is in a downtrend: it's below all five of its weekly moving averages, and 26% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over BROS on trend strength, trading above more of its moving averages.
BROS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $43.6 | $52.9 | +21% |
| 2022 | $52.9 | $30.1 | -43% |
| 2023 | $30.1 | $31.7 | +5.3% |
| 2024 | $31.7 | $53.4 | +68% |
| 2025 | $53.4 | $64.0 | +20% |
| 2026 YTD | $64.0 | $33.7 | -47% |
BROS is down 47% so far in 2026, after finishing higher in four of the previous five years.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over BROS on returns for 2026, with the stronger performance.